EN HU

Tornai Dávid

Tornai Dávid

Publication list

Uploaded publications:
48
Publications in DEA:
48
OA:
21
Date range:
2011-2026
2026
1.
Tornai, D., Papp, M.: Editorial: Decoding Gut Failure in Cirrhosis-Villin-1 and the Emergence of a Seventh Organ Failure. Authors' Reply.
Aliment. Pharmacol. Ther. [Epub ahead of print], 2026.
2.
Tornai, D., Papp, M.: Letter: Attempted Validation of Villin-1 as a Gut Barrier Marker in Decompensated Cirrhosis-Potential Confounding by Tubular Injury and Aetiology: Authors' Reply.
Aliment. Pharmacol. Ther. [Epub ahead of print], 2026.
3.
Tornai, D., Mitchell, M. C., McClain, C., Dasarathy, S., Barton, B., Szabó, G.: Longitudinal assessment of circulating cytokine profile of severe alcohol-associated hepatitis.
Hepatology. [Epub ahead of print], 2026.
Journal metrics:
D1 Hepatology (2025)
D1 Medicine (miscellaneous) (2025)
4.
Tornai, D., Balogh, B., Csillag, A., Budai, A., Kiss, A., Antal-Szalmás, P., Méhes, G., Baráth, L., Tornai, T. I., Tornai, I., Vitális, Z., Sipeki, N., Dinya, T., Enyedi, A., Rosenberger, F. A., Laleman, W., Coenraad, M., Aguilar, F., Claria, J., Moreau, R., Trebica, J., Papp, M., ICROB-PREDICT & PREDICT study group of the EASL-CLIF consortium: Serum Villin-1 - A novel marker of gut barrier damage in acutely decompensated cirrhosis: a cohort study and validation.
Aliment. Pharmacol. Ther. 63 (7), 1018-1032, 2026.
Journal metrics:
D1 Gastroenterology (2025)
Q1 Hepatology (2025)
D1 Pharmacology (medical) (2025)
2025
5.
Szabó, A., Lénárt, Á., Papp, M., Sipeki, N., Tornai, D.: A bélbarrier-károsodás jelentősége gyulladásos bélbetegségekben.
Cent. Eur. J. Gastroenterol. Hepatol. 11 (4), 151-157, 2025.
6.
Fehér, K. E., Tornai, D., Papp, M.: Hematological Parameter-Derived Inflammatory Scores in Non-Pancreatic Hyperlipasemia (NPHL)-The Prognosis Lies in the Blood.
Biomedicines. 13 (7), 1-17, (article identifier: 1719), 2025.
Journal metrics:
Q1 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
7.
Papp, M., Tornai, D.: Immunoglobulin A antibodies: prognostic tools with unknown mechanism in primary sclerosing cholangitis.
Pol. Arch. Intern. Med. 135 (1), 1-2, (article identifier: 16938), 2025.
8.
Vén, P. L., Tornai, D., Tóth, B., Vitális, Z., Tornai, I., Tornai, T. I., Pár, G., Papp, M.: Longitudinal Comparison of Currently Used Risk Scores for Prognostication of Primary Sclerosing Cholangitis (PSC) in a Hungarian Bicenter PSC Cohort.
Diagnostics. 15 (17), 1-15, (article identifier: 2166), 2025.
Journal metrics:
Q2 Clinical Biochemistry
Q2 Internal Medicine
9.
Élthes, Z. B., Vitális, Z., Papp, M., Tornai, T. I., Tornai, D., Tornai, I.: Long Term Follow-Up of Patients with Cryoglobulinemia After Successful Treatment of Chronic C Virus Hepatitis.
Dig. Dis. Sci. 70, 2467-2474, 2025.
Journal metrics:
Q2 Gastroenterology
Q2 Physiology
10.
Balogh, B., Tornai, D., Csillag, A., Tornai, I., Vitális, Z., Kováts, P., Antal-Szalmás, P., Dinya, T., Laleman, W., Coenraad, M., Trebica, J., Papp, M., MICROB-PREDICT Consortium: Secretory IgA Is a Key Marker Among Gut Barrier Dysfunction-Related Immunoglobulins Predicting Outcomes in ACLF.
Liver Int. 45 (10), 1-12, (article identifier: 70350), 2025.
Journal metrics:
Q1 Hepatology
2024
11.
Fehér, K. E., Tornai, D., Vitális, Z., Dávida, L., Sipeki, N., Papp, M.: Non-pancreatic hyperlipasemia: a puzzling clinical entity.
World J. Gastroenterol. 30 (19), 2538-2552, 2024.
Journal metrics:
Q1 Gastroenterology
Q1 Medicine (miscellaneous)
12.
Torp, N., Israelsen, M., Coenraad, M., Papp, M., Shawcross, D. L., Korenjak, M., Angeli, P., Laleman, W., Juanola, A., Ginès, P., Trebica, J., Krag, A., MICROB-PREDICT Consortium: Personalised human albumin in patients with cirrhosis and ascites: design and rationale for the ALB-TRIAL - a randomised clinical biomarker validation trial.
BMJ Open. 14 (2), 1-8, (article identifier: 079309), 2024.
13.
Bozsó Boglárka,, Mogyoróssy, S., Tornai, D., Kováts, P., Balogh, B., Sipeki, N., Oláh, F., Antal-Szalmás, P., Vitális, Z., Tornai, I., Schramm, C., Papp, M.: THU-106-YI Prospective european reference network registry (R-LIVER) supports improvement in bone disease care delivery at local level for patients with autoimmune liver diseases and enables detailed description of risk elements.
J. Hepatol. 80 (Suppl_1), S313, 2024.
2023
14.
Tornai, D., Mitchell, M., McClain, C., Dasarathy, S., McCullough, A., Radaeva, S., Kroll-Desrosiers, A., Lee, J., Barton, B., Szabó, G.: A novel score of IL-13 and age predicts 90-day mortality in severe alcohol-associated hepatitis: a multicenter plasma biomarker analysis.
Hepatol. Commun. 7 (12), 1-13, (article identifier: 0296), 2023.
Journal metrics:
Q1 Hepatology
15.
Sciascia, S., Bizzaro, N., Meroni, P. L., Bogdanos, D. P., Borghi, M. O., Bossuyt, X., Grossi, C., Tornai, D., Papp, M., Shoenfeld, Y., Ielo, D., Fritzler, M. J.: Autoantibodies testing in autoimmunity: Diagnostic, prognostic and classification value.
Autoimmun. Rev. 22 (7), 1-9, (article identifier: 103356), 2023.
Journal metrics:
Q1 Immunology
D1 Immunology and Allergy
16.
Cho, Y., Bukong, T. N., Tornai, D., Babuta, M., Vlachos, I. S., Kanata, E., Catalano, D., Szabó, G.: Neutrophil extracellular traps contribute to liver damage and increase defective low-density neutrophils in alcoholic hepatitis.
J. Hepatol. 78 (1), 28-44, 2023.
Journal metrics:
D1 Hepatology
17.
Walmsley, M., Tornai, D., Cazzagon, N., Leburgue, A., Mrzljak, A., Lenzen, H., Carbone, M., Madaleno, J., Lleo, A., Junge, N., Schramm, C., Bergquist, A.: Patient-reported quality of care in primary sclerosing cholangitis.
Liver Int. 43 (8), 1654-1662, 2023.
Journal metrics:
Q1 Hepatology
18.
Tornai, D., Balogh, B., Csillag, A., Budai, A., Kiss, A., Antal-Szalmás, P., Méhes, G., Baráth, L., Tornai, T. I., Tornai, I., Vitális, Z., Sipeki, N., Kováts, P., Trebica, J., Papp, M.: Serum villin-1 level-a tell-tale sign of gut barrier failure in patients with cirrhosis and acute decompensation.
J. Hepatol. 78 (Supplement), S25, 2023.
19.
Janka, T., Tornai, D., Papp, M., Vitális, Z.: The Value of Neutrophil-to-Lymphocyte Ratio to Identify Bacterial Infection and Predict Short-Term Mortality in Patients with Acutely Decompensated Cirrhosis.
Diagnostics. 13 (18), 1-14, (article identifier: 2954), 2023.
Journal metrics:
Q2 Clinical Biochemistry
2022
20.
Vitális, Z., Balogh, B., Tornai, D., Papp, M.: A máj-cirrhosis akut dekompenzációja.
Orvostovábbk. szle. 29 (3), 57-71, 2022.
21.
Szabó, G., Mitchell, M., McClain, C., Dasarathy, S., Barton, B., McCullough, A., Nagy, L. E., Kroll-Desrosiers, A., Tornai, D., Min, H. A., Radaeva, S., Holbein, M. E. B., Casey, L., Cuthbert, J.: IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis.
Hepatology. 76 (4), 1058-1068, 2022.
Journal metrics:
D1 Hepatology
D1 Medicine (miscellaneous)
22.
Szabó, G., Mitchell, M., McClain, C., Dasarathy, S., Barton, B., McCullough, A., Nagy, L. E., Kroll-Desrosiers, A., Tornai, D., Min, H. A., Radaeva, S., Casey, L., Cuthbert, J.: Response from Authors of HEP-21-2131.R1.
Hepatology. 76 (5), E114-E115, 2022.
23.
Tornai, D., Vén, P. L., Lakatos, P., Papp, M.: Serological biomarkers for management of primary sclerosing cholangitis.
World J. Gastroenterol. 28 (21), 2291-2301, 2022.
Journal metrics:
Q1 Gastroenterology
Q1 Medicine (miscellaneous)
2021
24.
Tornai, D., Antal-Szalmás, P., Tornai, T. I., Papp, M., Tornai, I., Sipeki, N., Janka, T., Balogh, B., Vitális, Z.: Abnormal ferritin levels predict development of poor outcomes in cirrhotic outpatients: a cohort study.
BMC Gastroenterol. 21 (1), 1-13, (article identifier: 94), 2021.
Journal metrics:
Q2 Gastroenterology
Q2 Medicine (miscellaneous)
25.
Tornai, D., Papp, M.: Editorial: serologic antibodies in primary sclerosing cholangitis - a tell-tale sign of compromised gut-liver immunity?.
Aliment. Pharmacol. Ther. 53 (2), 350-351, 2021.
Journal metrics:
D1 Gastroenterology
D1 Hepatology
D1 Pharmacology (medical)
DEENK University of Debrecen
© 2012 University of Debrecen